Search research articles
Contact Us
Filters
Showing results (121-130 of 168) with videos related to
Page
of 17
Sort By:
Antimicrobial Agents and Chemotherapy
|
January 11, 2017
Evidence To Support Continuation of Statin Therapy in Patients with Staphylococcus aureus Bacteremia
Aisling R Caffrey, Tristan T Timbrook, Eunsun Noh, et al.
The Journal of Infectious Diseases
|
November 17, 2005
Active immunization with a detoxified endotoxin vaccine protects against lethal polymicrobial sepsis: its use with CpG adjuvant and potential mechanisms
Steven M Opal, John E Palardy, Wilbur H Chen, et al.
American Journal of Respiratory and Critical Care Medicine
|
August 8, 2015
The Central Role of Proprotein Convertase Subtilisin/Kexin Type 9 in Septic Pathogen Lipid Transport and Clearance
Keith R Walley, Gordon A Francis, Steven M Opal, et al.
Journal of Clinical Microbiology
|
August 2, 2013
Subtyping clinical specimens of influenza A virus by use of a simple method to amplify RNA targets
Jingjing Wang, Warren Tai, Stephanie L Angione, et al.
Critical Care Medicine
|
January 6, 2007
Longitudinal studies of inter-alpha inhibitor proteins in severely septic patients: a potential clinical marker and mediator of severe sepsis
Steven M Opal, Yow-Pin Lim, Edward Siryaporn, et al.
Journal of Clinical Immunology
|
May 28, 2013
Recurrent Burkholderia gladioli suppurative lymphadenitis associated with neutralizing anti-IL-12p70 autoantibodies
Bich-Thuy T Sim, Sarah K Browne, Marguerite Vigliani, et al.
The Journal of Infectious Diseases
|
October 13, 2004
Chloroquine enhances survival in Bacillus anthracis intoxication
Andrew W Artenstein, Steven M Opal, Patricia Cristofaro, et al.
Critical Care Medicine
|
June 7, 2006
WAY-202196, a selective estrogen receptor-beta agonist, protects against death in experimental septic shock
Patricia A Cristofaro, Steven M Opal, John E Palardy, et al.
Critical Care Medicine
|
August 8, 2009
Phase 2 trial of eritoran tetrasodium (E5564), a toll-like receptor 4 antagonist, in patients with severe sepsis
Mark Tidswell, William Tillis, Steven P Larosa, et al.
Infection and Immunity
|
July 26, 2005
Inter-alpha-inhibitor proteins are endogenous furin inhibitors and provide protection against experimental anthrax intoxication
Steven M Opal, Andrew W Artenstein, Patricia A Cristofaro, et al.
Page
of 17
Search research articles
Search
Showing results (121-130 of 168) with videos related to
Sort By:
Page
of 17
Antimicrobial Agents and Chemotherapy
|
January 11, 2017
Evidence To Support Continuation of Statin Therapy in Patients with Staphylococcus aureus Bacteremia
Aisling R Caffrey, Tristan T Timbrook, Eunsun Noh, et al.
The Journal of Infectious Diseases
|
November 17, 2005
Active immunization with a detoxified endotoxin vaccine protects against lethal polymicrobial sepsis: its use with CpG adjuvant and potential mechanisms
Steven M Opal, John E Palardy, Wilbur H Chen, et al.
American Journal of Respiratory and Critical Care Medicine
|
August 8, 2015
The Central Role of Proprotein Convertase Subtilisin/Kexin Type 9 in Septic Pathogen Lipid Transport and Clearance
Keith R Walley, Gordon A Francis, Steven M Opal, et al.
Journal of Clinical Microbiology
|
August 2, 2013
Subtyping clinical specimens of influenza A virus by use of a simple method to amplify RNA targets
Jingjing Wang, Warren Tai, Stephanie L Angione, et al.
Critical Care Medicine
|
January 6, 2007
Longitudinal studies of inter-alpha inhibitor proteins in severely septic patients: a potential clinical marker and mediator of severe sepsis
Steven M Opal, Yow-Pin Lim, Edward Siryaporn, et al.
Journal of Clinical Immunology
|
May 28, 2013
Recurrent Burkholderia gladioli suppurative lymphadenitis associated with neutralizing anti-IL-12p70 autoantibodies
Bich-Thuy T Sim, Sarah K Browne, Marguerite Vigliani, et al.
The Journal of Infectious Diseases
|
October 13, 2004
Chloroquine enhances survival in Bacillus anthracis intoxication
Andrew W Artenstein, Steven M Opal, Patricia Cristofaro, et al.
Critical Care Medicine
|
June 7, 2006
WAY-202196, a selective estrogen receptor-beta agonist, protects against death in experimental septic shock
Patricia A Cristofaro, Steven M Opal, John E Palardy, et al.
Critical Care Medicine
|
August 8, 2009
Phase 2 trial of eritoran tetrasodium (E5564), a toll-like receptor 4 antagonist, in patients with severe sepsis
Mark Tidswell, William Tillis, Steven P Larosa, et al.
Infection and Immunity
|
July 26, 2005
Inter-alpha-inhibitor proteins are endogenous furin inhibitors and provide protection against experimental anthrax intoxication
Steven M Opal, Andrew W Artenstein, Patricia A Cristofaro, et al.
Page
of 17